Literature DB >> 3082025

Ocular allergy and mast cell stabilizers.

M R Allansmith, R N Ross.   

Abstract

The role of the mast cell in ocular allergy is becoming understood. As a result, the therapeutic effects of agents that stabilize the mast cell have been evaluated in the treatment of seasonal allergic conjunctivitis, vernal keratoconjunctivitis, atopic keratoconjunctivitis, and giant papillary conjunctivitis. At present, cromolyn sodium is the only available mast cell stabilizer of known effectiveness. Clinical and laboratory investigations of the effectiveness of cromolyn sodium in the treatment of ocular allergy are reviewed in the present article.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3082025     DOI: 10.1016/0039-6257(86)90119-0

Source DB:  PubMed          Journal:  Surv Ophthalmol        ISSN: 0039-6257            Impact factor:   6.048


  8 in total

1.  The effect of BCG-PSN on T-cell subsets and cytokines in vernal conjunctivitis.

Authors:  Jun Hu; Huan Chen
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2002

Review 2.  Systematic review and meta-analysis of randomised clinical trials on topical treatments for vernal keratoconjunctivitis.

Authors:  F Mantelli; M S Santos; T Petitti; R Sgrulletta; M Cortes; A Lambiase; S Bonini
Journal:  Br J Ophthalmol       Date:  2007-06-22       Impact factor: 4.638

Review 3.  Allergic eye disease mechanisms.

Authors:  J I McGill; S T Holgate; M K Church; D F Anderson; A Bacon
Journal:  Br J Ophthalmol       Date:  1998-10       Impact factor: 4.638

4.  A double blind placebo controlled group comparative study of ophthalmic sodium cromoglycate and nedocromil sodium in the treatment of vernal keratoconjunctivitis.

Authors:  M el Hennawi
Journal:  Br J Ophthalmol       Date:  1994-05       Impact factor: 4.638

5.  Treatment of common ocular allergic disorders; a comparison of lodoxamide and NAAGA.

Authors:  D Denis; E Bloch-Michel; P Verin; A Sebastiani; M Tazartes; L Helleboid; A Di Giovanni; M Lecorvec
Journal:  Br J Ophthalmol       Date:  1998-10       Impact factor: 4.638

6.  Vernal keratoconjunctivitis and trachoma.

Authors:  M H Friedlaender; J Cameron
Journal:  Int Ophthalmol       Date:  1988       Impact factor: 2.031

7.  Quiescent and Active Tear Protein Profiles to Predict Vernal Keratoconjunctivitis Reactivation.

Authors:  Alessandra Micera; Antonio Di Zazzo; Graziana Esposito; Roberto Sgrulletta; Virginia L Calder; Stefano Bonini
Journal:  Biomed Res Int       Date:  2016-02-17       Impact factor: 3.411

Review 8.  Efficacy, Safety and Steroid-sparing Effect of Topical Cyclosporine A 0.05% for Vernal Keratoconjunctivitis in Indian Children.

Authors:  Arkendu Chatterjee; Sabyasachi Bandyopadhyay; Samir Kumar Bandyopadhyay
Journal:  J Ophthalmic Vis Res       Date:  2019-10-24
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.